Clinical Trial Detail

NCT ID NCT03524170
Title RACHEL1: Radiation and CHEckpoint bLockade Trial in Patients With Metastatic Hormone Receptor Positive, HER2 Negative Breast Cancer
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements yes
Sponsors M.D. Anderson Cancer Center
Indications

Her2-receptor negative breast cancer

Therapies

M7824

Age Groups: senior adult

Additional content available in CKB BOOST